PATENT CLAIM ANALYSIS

Application Number: 16225894
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "618000"]

Abstract:
The present application relates to compounds according to (Formula IA) or (Formula IB): or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases.

Claim (Index 17):
The method according to  claim 16 , wherein the at least one condition is selected from the group consisting of rheumatoid arthritis, psoriasis, inflammatory bowel disease, Crohn's disease and multiple sclerosis.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15829226', '15102098', '15579164', '15578997', '15579111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7965881026321547
- 35 USC 102 Novelty (BERT): 0.5580219522029845
- Combined Prediction Score: 0.7727314875892377
- Mean Citation Score: 339.039382
- Max Citation Score: 476.3625
- Similarity Product: 271.00446664318446

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test